Title : The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer.

Pub. Date : 2015 Jun 5

PMID : 25514466






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We therefore present the case that in the context of the DHEA-S depot, P450c17 and AKR1C3 inhibition may be an effective combinatorial treatment strategy. Dehydroepiandrosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens